Serum Phosphorus and mortality in the Third National Health and Nutrition Examination Survey (NHANES III): Effect modification by fasting

American Journal of Kidney Diseases

Volumn 64, Issue 4, 2014, Pages 567-573

  Chang, Alex R ^a   Grams, Morgan E ^b,c  

^a GEISINGER HEALTH SYSTEM   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

cardiovascular; death; fast; fasting; mortality; phosphate; Phosphorus

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; CARDIOVASCULAR MORTALITY; DEATH CERTIFICATE; DIET RESTRICTION; DIETARY INTAKE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHOSPHATE BLOOD LEVEL; REVIEW; THIRD NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY; BLOOD; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COHORT ANALYSIS; EPIDEMIOLOGY; MIDDLE AGED; NUTRITION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICS; TIME; UNITED STATES;

ADULT; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; EFFECT MODIFIER, EPIDEMIOLOGIC; FASTING; FEMALE; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PHOSPHORUS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STATISTICS AS TOPIC; TIME FACTORS; UNITED STATES;

EID: 84908120839     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2014.04.028     Document Type: Article

References (48)

1. M. Tonelli, F. Sacks, M. Pfeffer, Z. Gao, G. Curhan Cholesterol And Recurrent Events Trial Investigators Relation between serum phosphate level and cardiovascular event rate in people with coronary disease Circulation 112 17 2005 2627 2633
2. R. Dhingra, L.M. Sullivan, and C.S. Fox Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community Arch Intern Med 167 9 2007 879 885
3. R.N. Foley, A.J. Collins, C.A. Herzog, A. Ishani, and P.A. Kalra Serum phosphorus levels associate with coronary atherosclerosis in young adults J Am Soc Nephrol 20 2 2009 397 404
4. K.R. Tuttle, and R.A. Short Longitudinal relationships among coronary artery calcification, serum phosphorus, and kidney function Clin J Am Soc Nephrol 4 12 2009 1968 1973
5. L.L. Haut, A.C. Alfrey, S. Guggenheim, B. Buddington, and N. Schrier Renal toxicity of phosphate in rats Kidney Int 17 6 1980 722 731
6. E. Shuto, Y. Taketani, and R. Tanaka Dietary phosphorus acutely impairs endothelial function J Am Soc Nephrol 20 7 2009 1504 1512
7. B. Kestenbaum, J.N. Sampson, and K.D. Rudser Serum phosphate levels and mortality risk among people with chronic kidney disease J Am Soc Nephrol 16 2 2005 520 528
8. N. Voormolen, M. Noordzij, and D.C. Grootendorst High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients Nephrol Dial Transplant 22 10 2007 2909 2916
9. C.P. Kovesdy, J.E. Anderson, and K. Kalantar-Zadeh Outcomes associated with serum phosphorus level in males with non-dialysis dependent chronic kidney disease Clin Nephrol 73 4 2010 268 275
10. R. Mehrotra, C.A. Peralta, and S.C. Chen No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease Kidney Int 84 5 2013 989 997
11. V. Menon, T. Greene, and A.A. Pereira Relationship of phosphorus and calcium-phosphorus product with mortality in CKD Am J Kidney Dis 46 3 2005 455 463
12. A.A. Portale, B.P. Halloran, and R.C. Morris Jr. Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D J Clin Invest 80 4 1987 1147 1154
13. W. Jubiz, J.M. Canterbury, E. Reiss, and F.H. Tyler Circadian rhythm in serum parathyroid hormone concentration in human subjects: correlation with serum calcium, phosphate, albumin, and growth hormone levels J Clin Invest 51 8 1972 2040 2046
14. M.R. Wills The effect of diurnal variation on total plasma calcium concentration in normal subjects J Clin Pathol 23 9 1970 772 777
15. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. Vital Health Stat 1. 1994;(32)(32):1-407.
16. A.S. Levey, L.A. Stevens, and C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 9 2009 604 612
17. NHANES III linked mortality file 2009 Centers for Disease Control and Prevention Atlanta, GA [updated September 25; cited August 13, 2012] http://www.cdc.gov/nchs/data-access/data-linkage/mortality/nhanes3-linkage.htm#analytic Accessed May 20, 2013
18. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th revision. (ICD-10-CM). Geneva, Switzerland: World Health Organization; 1992.
19. R.A. Fisher Frequency distribution of the values of the correlation coefficients in samples from an indefinitely large population Biometrika 10 4 1915 507 521
20. 3, calcium, and phosphorus homeostasis in postmenopausal women Endocr Res 36 2 2011 45 52
21. J.R. Masarei The effect of 50 grams of glucose orally on a number of biochemical variables Pathology 9 1 1977 19 25
22. A.E. Bowe, R. Finnegan, and S.M. Jan de Beur FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate Biochem Biophys Res Commun 284 4 2001 977 981
23. M. Wolf Update on fibroblast growth factor 23 in chronic kidney disease Kidney Int 82 7 2012 737 747
24. C. Faul, A.P. Amaral, and B. Oskouei FGF23 induces left ventricular hypertrophy J Clin Invest 121 11 2011 4393 4408
25. J.H. Ix, R. Katz, and B.R. Kestenbaum Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study) J Am Coll Cardiol 60 3 2012 200 207
26. O.M. Gutierrez, J.L. Januzzi, and T. Isakova Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease Circulation 119 19 2009 2545 2552
27. J.J. Scialla, B.C. Astor, T. Isakova, H. Xie, L.J. Appel, and M. Wolf Mineral metabolites and CKD progression in african americans J Am Soc Nephrol 24 1 2013 125 135
28. M. Abramowitz, P. Muntner, and M. Coco Serum alkaline phosphatase and phosphate and risk of mortality and hospitalization Clin J Am Soc Nephrol 5 6 2010 1064 1071
29. M. Tonelli, G. Curhan, and M. Pfeffer Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality Circulation 120 18 2009 1784 1792
30. C.P. Kovesdy, V. Ureche, J.L. Lu, and K. Kalantar-Zadeh Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD Nephrol Dial Transplant 25 9 2010 3003 3011
31. C. Drechsler, M. Verduijn, and S. Pilz Bone alkaline phosphatase and mortality in dialysis patients Clin J Am Soc Nephrol 6 7 2011 1752 1759
32. K. Iba, J. Takada, and T. Yamashita The serum level of bone-specific alkaline phosphatase activity is associated with aortic calcification in osteoporosis patients J Bone Miner Metab 22 6 2004 594 596
33. K.T. Yamamoto, C. Robinson-Cohen, and M.C. de Oliveira Dietary phosphorus is associated with greater left ventricular mass Kidney Int 83 4 2013 707 714
34. A.R. Chang, M. Lazo, L.J. Appel, O.M. Gutierrez, and M.E. Grams High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III Am J Clin Nutr 99 2 2014 320 327
35. T. Isakova, O.M. Gutierrez, and Y. Chang Phosphorus binders and survival on hemodialysis J Am Soc Nephrol 20 2 2009 388 396
36. G.M. Chertow, S.K. Burke, P. Raggi Treat to Goal Working Group Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients Kidney Int 62 1 2002 245 252
37. W.N. Suki, R. Zabaneh, and J.L. Cangiano Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients Kidney Int 72 9 2007 1130 1137
38. B. Di Iorio, D. Molony, and C. Bell Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial Am J Kidney Dis 62 4 2013 771 778
39. G.A. Block, D.C. Wheeler, and M.S. Persky Effects of phosphate binders in moderate CKD J Am Soc Nephrol 23 8 2012 1407 1415
40. J.B. Leon, C.M. Sullivan, and A.R. Sehgal The prevalence of phosphorus-containing food additives in top-selling foods in grocery stores J Ren Nutr 23 4 2013 265 270.e2
41. M.S. Calvo, and J. Uribarri Contributions to total phosphorus intake: all sources considered Semin Dial 26 1 2013 54 61
42. I.H. de Boer, T.C. Rue, and B. Kestenbaum Serum phosphorus concentrations in the Third National Health and Nutrition Examination Survey (NHANES III) Am J Kidney Dis 53 3 2009 399 407
43. S.A. Kempson, M. Lotscher, B. Kaissling, J. Biber, H. Murer, and M. Levi Parathyroid hormone action on phosphate transporter mRNA and protein in rat renal proximal tubules Am J Physiol 268 4, pt 2 1995 F784 F791
44. R.A. Kaplan, M.R. Haussler, L.J. Deftos, H. Bone, and C.Y. Pak The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria J Clin Invest 59 5 1977 756 760
45. T. Berndt, L.F. Thomas, and T.A. Craig Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption Proc Natl Acad Sci U S A 104 26 2007 11085 11090
46. S. Faroqui, M. Levi, M. Soleimani, and H. Amlal Estrogen downregulates the proximal tubule type IIa sodium phosphate cotransporter causing phosphate wasting and hypophosphatemia Kidney Int 73 10 2008 1141 1150
47. M. Cirillo, C. Ciacci, and N.G. De Santo Age, renal tubular phosphate reabsorption, and serum phosphate levels in adults N Engl J Med 359 8 2008 864 866
48. J.H. Ix, M. Chonchol, G.A. Laughlin, M.G. Shlipak, and M.A. Whooley Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: the Heart and Soul Study Am J Kidney Dis 58 5 2011 737 745